An investigational peptide developed for advanced research. Strictly intended for research use only.
*LC-MS identity confirmation may be performed when analytical review indicates conflicting, atypical, or inconclusive results.
AOD-9604 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone (hGH), specifically engineered to isolate and study the lipolytic (fat-metabolizing) properties of hGH without its broader anabolic or growth-promoting effects. It is commonly investigated for its role in regulating fat metabolism, lipid mobilization, and body composition in controlled research settings. This peptide functions by mimicking the fat-reducing segment of hGH, stimulating lipolysis—the breakdown of stored triglycerides into free fatty acids—while simultaneously inhibiting lipogenesis, the process by which new fat is formed. Through this dual mechanism, AOD-9604 supports enhanced fat utilization and may contribute to reductions in adipose tissue under experimental conditions. Unlike full-length growth hormone, AOD-9604 does not appear to significantly influence insulin-like growth factor-1 (IGF-1) levels or promote cell proliferation. This targeted activity allows researchers to examine fat metabolism pathways without the confounding systemic effects typically associated with hGH, such as increased tissue growth or alterations in blood glucose regulation. Preclinical studies suggest that AOD-9604 may enhance metabolic efficiency by increasing the rate at which stored fat is oxidized for energy. These effects are associated with improved lipid profiles and may support investigations into obesity-related metabolic dysfunction and weight regulation. In addition to its lipolytic properties, AOD-9604 has been explored for its potential influence on cartilage and tissue repair processes, though these effects remain secondary to its primary metabolic focus. Ongoing research continues to evaluate its broader physiological impact and long-term safety profile. AOD-9604 is primarily utilized in laboratory and experimental research to study fat metabolism, obesity pathways, and metabolic regulation. Its selective mechanism makes it a useful tool for isolating the metabolic actions of growth hormone-derived peptides without systemic endocrine effects.
Each batch undergoes analytical review using validated laboratory procedures. HPLC testing is utilized to assess purity and compare the sample profile against established reference standards. Where additional verification is warranted, LC-MS analysis may be performed to support compound identity confirmation.
*See LC-MS Confirmation Information for full details.
Every batch supplied by KVR3 Compound Research is assigned a unique batch number and maintained under documented quality-control procedures with supporting analytical documentation available upon request.
No reviews yet — be the first to review this product.
For Research Use Only. This product is intended solely for laboratory and scientific research where permitted by applicable laws and regulations. Not intended for human or veterinary use. It is not intended for diagnostic, therapeutic, or clinical applications.
At KVR3, we are committed to providing research products supported by transparent documentation and quality-focused processes. Where available, each batch is accompanied by analytical documentation to help researchers evaluate product specifications.
All KVR3 Compound Research orders are shipped directly from within Canada, ensuring efficient delivery, reliable service, and consistent quality-control from fulfillment to arrival.
No reviews yet — be the first to review this product.
